Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Another cost of generic Prilosec

Executive Summary

Andrx notes in Nov. 15 10-Q filing that scale-up for the expected launches of generic omeprazole and bupropion has affected production of commercial products. "Through much of 2002, besides the currently marketed products, the company was concurrently working toward building launch quantities for two significant potential product candidates, bioequivalent versions of Prilosec and Wellbutrin SR/Zyban, which resulted in inefficiencies, equipment failures and rejection lots, and at times interrupted the company's ability to fully meet the actual demand for certain of its products," Andrx said. Generic Prilosec launch supplies will not be used after a federal court ruled that Andrx infringed AstraZeneca's patents...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS040785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel